Stocks
Crypto is buzzing, its scammers are too
Cryptocurrency is having a moment. On the campaign trail, Trump vowed to make the US “the crypto capital of the planet.
Reporter
Laura Turbay
Company Insights
Eli Lilly races to fend off competitors in weight-loss drug market
Eli Lilly bulks up on supply and lawsuits to ward off competition in the booming weight loss market
Pharmaceuticals
Eli Lilly stock falls 13% after disappointing sales for Mounjaro and Zepbound in the third quarter
Eli Lilly lowered its revenue forecasts for the full year after an inventory drawdown by wholesalers weighed on sales for blockbuster weight loss and diabetes drugs.
Company Insights
Eli Lilly’s New Alzheimer’s Drug Wins Approval In Japan
An experimental Eli Lilly drug for Alzheimer’s treatment was approved last week for use in Japan, which has one of the world’s largest aging populations. The U.S.
COVID-19
Small biotech poised for a cure after years of plunging stock
Small-cap biotech stocks plundered after a 2021 wild-run, but investors are hopeful that interest rate cuts and positive test results in oncology and autoimmune treatments will be the right prescription for the biopharma market.